MySubsidy

Production Linked Incentive (PLI) Scheme for Pharmaceuticals

Ministry of Chemicals and Fertilizers · Central government

The scheme provides financial incentives on incremental sales of pharmaceutical goods and in-vitro diagnostic medical devices to boost domestic manufacturing.

Open, rolling. Applications are accepted continuously — there is no deadline.

Key facts

Subsidy amount
₹15,00,000 – ₹10,00,00,00,000
Instrument
Subsidy
Deadline
Rolling
Disbursement
Released against milestones
Scheme duration
73 months

About this scheme

The Production Linked Incentive (PLI) Scheme for Pharmaceuticals was introduced by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers. Its stated purpose is to expand domestic manufacturing capacity in the pharmaceutical sector, encourage higher investment and output, and shift production towards high-value items such as advanced pharmaceutical products and in-vitro diagnostic medical devices. Incentives are calculated on incremental sales relative to a defined base year, with the aim of positioning India as a major participant in the global pharmaceutical supply chain.

The Small Industries Development Bank of India (SIDBI) serves as the Project Management Agency (PMA) for the scheme. SIDBI handles application processing and manages incentive disbursal through a dedicated online portal. The programme is intended to reinforce the domestic pharmaceutical ecosystem, support innovation, and lessen dependence on imported critical ingredients and finished formulations.

Who can apply

Eligible business forms
Private limited company, Limited liability partnership, One person company, Partnership firm, Sole proprietorship
Udyam registration
Not specified
MSME registration
Required
DPIIT startup recognition
Not specified
GST registration
Not specified
Revenue band
From ₹5,00,000
Where the business may be based
Not restricted

- Applicant must be a pharmaceutical goods manufacturer registered in India. - Applicant must be engaged in manufacturing eligible pharmaceutical products across the three defined categories. - Applicant must not claim incentives for the same product under other PLI schemes. - Group A Applicants: Global Manufacturing Revenue of pharmaceutical goods or in-vitro Diagnostic Medical Devices ≥ ₹5,000 crores in FY 2019-20; minimum cumulative investment of ₹1,000 crores over 5 years; minimum eligible product turnover of ₹50 crores in FY 2022-23. - Group B Applicants: Global Manufacturing Revenue between ₹500 crores and ₹5,000 crores in FY 2019-20; minimum cumulative investment of ₹250 crores over 5 years; minimum eligible product turnover of ₹10 crores in FY 2022-23. - Group C Applicants: Global Manufacturing Revenue less than ₹500 crores in FY 2019-20; minimum cumulative investment of ₹50 crores over 5 years; minimum eligible product turnover of ₹1 crore in FY 2022-23. - Group C (MSME) Applicants: Must fall under the Micro, Small and Medium Enterprises (MSME) category within Group C; commit eligible investment over 5 years; achieve a minimum eligible product turnover of ₹50 lakhs in FY 2022-23. - Continuation Criteria: Applicants must achieve a 7% growth in sales over the previous financial year for subsequent years (FY 2023-24 onwards) to continue claiming incentives.

How to apply

- **Step 1: Access the Portal:** Go to the official online portal at https://pli-pharma.udyamimitra.in. - **Step 2: Register and Apply:** Create an account on the portal and complete the application form in full, providing accurate information on your Global Manufacturing Revenue, investment commitments, and the pharmaceutical product categories relevant to your business. - **Step 3: Submit Application Fee:** Pay the non-refundable application fee as specified in the scheme guidelines. - **Step 4: Await Processing:** The Project Management Agency (SIDBI) will review submitted applications and rank them according to a predefined methodology. This evaluation is generally concluded within 90 days after the application window closes. - **Step 5: Receive Approval:** Successful applicants will be issued an official approval letter by the Project Management Agency. - **Step 6: Furnish Guarantees:** Within two weeks of receiving the approval letter, provide a Bank Guarantee for the prescribed amount and an Undertaking in favour of the Department of Pharmaceuticals. - **Step 7: Claim Incentives Annually:** Submit your annual claims for incentive disbursement through the online portal, along with all necessary supporting documents, within one month of the end of the financial year.

Apply on the issuer's site

How applications are assessed

Applications are processed and assessed by the Project Management Agency (SIDBI). A pre-defined ranking methodology determines selection, taking into account the applicant's Global Manufacturing Revenue, committed investments, and proposed product categories. Results are usually communicated within 90 days of the application window closing.

Frequently asked questions

What is the primary goal of the PLI Scheme for Pharmaceuticals?

The scheme seeks to strengthen domestic manufacturing, draw substantial investment, and encourage diversification into high-value pharmaceuticals and in-vitro diagnostic devices, thereby cutting import reliance.

Who is eligible to apply for this PLI scheme?

Applicants must be pharmaceutical manufacturers registered in India, producing goods within the scheme’s three categories. Eligibility is further determined by global manufacturing revenue and committed investment, with criteria set for Groups A, B, and C, including a sub-category for MSMEs in Group C.

How are the financial incentives calculated and paid out?

Incentives, ranging from 3% to 10% of net incremental sales over a base year, are paid over six years. Claims are filed annually online, with 75% released immediately and the balance after audited accounts are submitted.

What are the maximum incentives an applicant can receive?

The incentive cap is ₹10,000 crore per applicant for Group A companies, ₹2,500 crore for Group B companies, and ₹50 crore for Group C companies.

Is MSME registration required for this scheme?

MSMEs that meet the criteria for Group C can apply under its relaxed thresholds, though this sub-category is not universally required.

What is the application process for the PLI Pharma Scheme?

Applications are submitted online via the SIDBI portal, which serves as the designated Project Management Agency. The process includes registration, form completion, a non-refundable fee payment, and, if selected, submission of a Bank Guarantee and Undertaking; annual incentive claims are also filed through the same portal.

Sectors

  • Health Pharma Biotech
  • Pharmaceuticals
  • Pli Scheme
  • Manufacturing
  • Medical Devices
  • Drug Production
  • Incentives
  • Industry Growth

Details last verified on 3 August 2026. Source: the issuer's published information.